{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:31:37Z","timestamp":1775485897897,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijpt.2025.101295","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:42:01Z","timestamp":1766594521000},"page":"101295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin Lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"Daniela","family":"Martir-Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Bechtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Milner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond B.","family":"Mailhot Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2025.101295_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijpt.2025.101295_bib2","unstructured":"National Cancer Institute. National Childhood Cancer Registry Explorer (NCCR*Explorer): An interactive website for NCCR cancer statistics; 2024 Sep 26.\u00a0Accessed August 18, 2025.\u00a0https:\/\/nccrexplorer.ccdi.cancer.gov."},{"key":"10.1016\/j.ijpt.2025.101295_bib3","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijpt.2025.101295_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2016.01.053","article-title":"A comparative evaluation of normal tissue doses for patients receiving radiation therapy for Hodgkin Lymphoma on the childhood cancer survivor study and recent Children's Oncology Group Trials","volume":"95","author":"Zhou","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.101295_bib5","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijpt.2025.101295_bib6","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood-2023-189652","article-title":"AHOD2131: a randomized Phase 3 response-adapted trial comparing standard therapy with immuno-oncology therapy for children and adults with newly diagnosed Stage I and II classic hodgkin lymphoma","volume":"142","author":"Henderson","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ijpt.2025.101295_bib7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+AVD in advanced-stage classic Hodgkin's lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijpt.2025.101295_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ijrobp.2025.06.3876","article-title":"Comparison of contemporary radiation therapy approaches in combined modality treatment on pediatric high-risk classic hodgkin lymphoma study: AHOD 1331","volume":"123","author":"Hoppe","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.101295_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijrobp.2021.07.1716","article-title":"Radiation therapy across pediatric hodgkin lymphoma research group protocols: a report from the staging, evaluation, and response criteria harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group","volume":"112","author":"Hall","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.101295_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) lymphoma subcommittee","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2025.101295_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/pbc.26044","article-title":"Proton therapy for pediatric hodgkin lymphoma","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijpt.2025.101295_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2022.01.016","article-title":"Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: toxicity and outcomes in 50 patients","volume":"168","author":"Tringale","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2025.101295_bib13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","article-title":"Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma","volume":"28","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijpt.2025.101295_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamaoncol.2024.5648","article-title":"Transplant-free salvage therapy for low-risk relapsed pediatric hodgkin lymphoma: a nonrandomized clinical trial","volume":"11","author":"Hoppe","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijpt.2025.101295_bib15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2206660","article-title":"Brentuximab vedotin with chemotherapy in pediatric high-risk hodgkin's lymphoma","volume":"387","author":"Castellino","year":"2022","journal-title":"N Engl J Med"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025005608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025005608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:40:48Z","timestamp":1775482848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518025005608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":15,"alternative-id":["S2331518025005608"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.101295","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.101295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101295"}}